Ann Intern Med:肿瘤学:2023年你可能错过了什么

15天前 来源:Ann Intern Med

本文由小咖机器人翻译整理

期刊来源:Ann Intern Med

原文链接:https://doi.org/10.7326/M24-0520

摘要内容如下:

肿瘤治疗方法的进步改善了癌症患者的预后和生活质量。然而,这些患者的护理可能是复杂的,来自不同专业的医生的贡献是至关重要的。这篇文章重点介绍了2023年以来与肿瘤患者管理相关的广泛主题的重要出版物。对文献进行了筛选,以寻找与内科专家和非肿瘤学专科专家相关的重要新证据。两篇文章论述了针对低收入和少数族裔患者临终关怀的社会干预措施的重要性,以及照顾者的福祉。另外两篇文章阐述了结直肠癌和肺癌高危患者的筛查注意事项。另外两篇文章论述了在诊断为非侵袭性乳腺肿瘤的患者中安全使用激素相关疗法来治疗更年期症状和预防疾病复发或进展。最后,收录了几篇关于癌症患者COVID-19疫苗接种、使用大麻素控制癌症疼痛、使用免疫检查点抑制剂相关的慢性自身免疫不良反应以及第二原发性肿瘤发病率的文章。

英文原文如下:

Abstracts

Advances in oncology treatment methods have improved outcomes and quality of life for patients with cancer. However, care of these patients can be complex, and the contribution of physicians from different specialties is crucial. This article highlights important publications from 2023 on topics across a wide spectrum relating to the management of oncology patients. The literature was screened for significant new evidence that is relevant to internal medicine specialists and subspecialists whose focus is not oncology. Two articles address the importance of social interventions targeting end-of-life care for low-income and minority patients and the well-being of caregivers. Two additional articles address screening considerations in patients at risk for colorectal and lung cancer. Two more articles address safe use of hormone-related therapies to treat symptoms of menopause and prevent disease recurrence or progression in patients diagnosed with noninvasive breast neoplasia. Finally, several articles were included on topics related to COVID-19 vaccination in patients with cancer, use of cannabinoids for cancer pain control, chronic autoimmune adverse effects related to use of immune checkpoint inhibitors, and the incidence of second primary neoplasms.

-----------分割线---------

点击链接:https://www.mediecogroup.com/community/user/vip/categories/ ,成为医咖会员,获取12项专属权益。

评论
请先登录后再发表评论
发表评论
下载附件需认证
为保证平台的学术氛围,请先完成认证,认证可免费享受基础会员权益
基础课程券2张
专属科研工作台
200积分
确认
取消
公众号
统计咨询
扫一扫添加小咖个人微信,立即咨询统计分析服务!
会员服务
SCI-AI工具
积分商城
意见反馈